The Hidden Connection Between Prediabetes and PCOS

Polycystic Ovary Syndrome (PCOS) ranks among the most common endocrine disorders affecting women of reproductive age, with estimates suggesting 5% to 15% of this population live with the condition. Prediabetes, a metabolic state where blood glucose levels rise above normal but fall short of a type 2 diabetes diagnosis, has emerged as a critical concern for women with PCOS. Research increasingly demonstrates that these two conditions share a deep, bidirectional relationship driven by insulin resistance, hormonal disruption, and chronic low-grade inflammation. Recognizing and acting on this connection can change the trajectory of a woman’s metabolic and reproductive health for decades to come.

For many women, the reproductive symptoms of PCOS—irregular periods, unwanted hair growth, and difficulty conceiving—dominate the clinical picture. Meanwhile, the metabolic disturbances, including prediabetes, develop silently in the background. This article explores the science behind the PCOS–prediabetes link, the mechanisms that drive both conditions, and the practical steps women can take to protect their health.

What Are PCOS and Prediabetes?

Understanding each condition individually is essential before exploring how they interact.

Polycystic Ovary Syndrome (PCOS)

PCOS is diagnosed using the Rotterdam criteria, which require at least two of the following three features: irregular or absent ovulation (leading to fewer than eight menstrual cycles per year or cycles longer than 35 days), clinical or biochemical signs of hyperandrogenism such as elevated testosterone, hirsutism, acne, or male-pattern hair thinning, and polycystic ovaries visible on ultrasound, defined as 12 or more follicles measuring 2–9 mm in each ovary or an ovarian volume greater than 10 mL.

PCOS is a chronic condition with wide-ranging effects on fertility, metabolism, cardiovascular health, and mental well-being. The syndrome is heterogeneous; some women present primarily with metabolic disturbances while others experience mainly reproductive symptoms. This variability often leads to delayed diagnosis and fragmented care.

Prediabetes

Prediabetes is diagnosed through one of three laboratory measures: fasting blood glucose between 100–125 mg/dL, HbA1c between 5.7% and 6.4%, or a two-hour glucose level of 140–199 mg/dL during an oral glucose tolerance test (OGTT). Each test captures a slightly different aspect of glucose metabolism, and using only one can miss many cases.

The Centers for Disease Control and Prevention estimates that more than one in three American adults have prediabetes, and the majority are unaware of their status. Among women with PCOS, the prevalence is substantially higher. Prediabetes is not a benign condition; it carries an increased risk of cardiovascular disease, kidney disease, and progression to type 2 diabetes. However, it is also a reversible state when addressed early with lifestyle and medical interventions.

The connection between PCOS and prediabetes is not coincidental. These conditions share fundamental biological pathways that reinforce one another.

Insulin Resistance as the Central Driver

Insulin resistance sits at the heart of the PCOS–prediabetes connection. An estimated 50% to 80% of women with PCOS exhibit insulin resistance, independent of body weight. In this state, the body’s cells—particularly muscle, fat, and liver cells—become less responsive to insulin. The pancreas compensates by secreting more insulin, leading to hyperinsulinemia. Elevated insulin levels then stimulate the ovaries to produce excess androgens, worsening PCOS symptoms and further impairing metabolic function.

This creates a vicious cycle. Hyperinsulinemia promotes abdominal fat storage, which in turn worsens insulin resistance. The resulting metabolic strain accelerates the decline in pancreatic beta cell function, pushing women from normal glucose tolerance through prediabetes and eventually toward type 2 diabetes. The whole process can unfold over years or even decades, often without obvious symptoms until significant damage has occurred.

Chronic Inflammation

Both PCOS and prediabetes are characterized by a state of low-grade chronic inflammation. Adipose tissue, particularly visceral fat, releases pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). These molecules interfere with insulin signaling at the cellular level and contribute to ovarian dysfunction. Inflammatory markers like C-reactive protein (CRP) are often elevated in women with PCOS, even after adjusting for body mass index.

The inflammatory milieu also affects the hypothalamus and pituitary gland, potentially disrupting gonadotropin-releasing hormone (GnRH) pulsatility and contributing to the ovulatory dysfunction seen in PCOS. Addressing inflammation through diet, exercise, and stress management can therefore improve both metabolic and reproductive outcomes simultaneously.

Hormonal Disruption Beyond Androgens

While hyperandrogenism is a hallmark of PCOS, other hormonal changes also play a role in the link to prediabetes. Women with PCOS often have low levels of sex hormone-binding globulin (SHBG), a protein produced by the liver that binds to testosterone and estradiol. Low SHBG means more free, biologically active testosterone circulates in the blood, worsening PCOS symptoms. Low SHBG is also a strong independent predictor of insulin resistance and type 2 diabetes risk, even in women without PCOS.

Additionally, alterations in the hypothalamic-pituitary-ovarian axis affect luteinizing hormone (LH) secretion, with an elevated LH-to-FSH ratio commonly seen in PCOS. This hormonal environment further promotes ovarian androgen production and disrupts normal follicular development.

Risk Factors and Warning Signs

Recognizing the shared risk factors and early warning signs of both conditions empowers women to seek evaluation and intervention sooner.

Shared Risk Factors

  • Excess weight and central obesity: Visceral adiposity is strongly associated with insulin resistance. Up to 60–80% of women with PCOS are overweight or obese, though lean women with PCOS also face metabolic risk.
  • Family history: Having a first-degree relative with type 2 diabetes or PCOS increases the likelihood of developing both conditions. Genetic studies have identified overlapping susceptibility loci.
  • Sedentary lifestyle: Physical inactivity worsens insulin sensitivity independent of body weight and contributes to the metabolic disturbances seen in PCOS.
  • Poor dietary patterns: Diets high in refined carbohydrates, added sugars, and unhealthy fats promote hyperinsulinemia and inflammation, accelerating the progression from PCOS to prediabetes.
  • History of gestational diabetes: Women who develop diabetes during pregnancy face a substantially higher risk of both PCOS and future type 2 diabetes.

Warning Signs to Watch For

  • Irregular menstrual cycles: Cycles shorter than 21 days or longer than 35 days, or fewer than eight periods per year, indicate ovulatory dysfunction.
  • Unexplained weight gain or difficulty losing weight: Insulin resistance makes weight management more challenging and promotes abdominal fat storage.
  • Skin changes: Acanthosis nigricans—dark, velvety, thickened patches on the neck, groin, armpits, or under the breasts—is a classic sign of insulin resistance.
  • Persistent fatigue and energy crashes: Blood sugar fluctuations driven by insulin resistance can cause extreme tiredness, especially after meals.
  • Cravings for sweets and carbohydrates: Hyperinsulinemia triggers hunger and cravings, particularly for foods that rapidly raise blood glucose.
  • Mood changes: Depression and anxiety are more common in women with PCOS, and unstable blood glucose can worsen mood swings and irritability.

Many women dismiss these symptoms as normal or unrelated, delaying diagnosis and intervention. Healthcare providers should maintain a high index of suspicion, particularly when multiple warning signs are present.

Long-Term Health Implications of Untreated Prediabetes in PCOS

When prediabetes goes unrecognized or unaddressed in women with PCOS, the consequences extend well beyond diabetes risk.

Progression to Type 2 Diabetes

Women with PCOS face a two- to five-fold increased risk of developing type 2 diabetes compared to women without PCOS, even after adjusting for body weight. The progression from normal glucose tolerance to prediabetes to diabetes occurs more rapidly in this population. Studies suggest that up to 40% of women with PCOS will develop impaired glucose tolerance or type 2 diabetes by age 40.

Cardiovascular Disease

The combination of PCOS and prediabetes amplifies cardiovascular risk. Women with both conditions have higher rates of hypertension, dyslipidemia (elevated triglycerides, low HDL cholesterol, and small dense LDL particles), and endothelial dysfunction. The American Heart Association identifies PCOS as a risk-enhancing factor for cardiovascular disease, and the presence of prediabetes further escalates that risk. Left untreated, this translates into higher rates of heart attack, stroke, and peripheral artery disease later in life.

Non-Alcoholic Fatty Liver Disease (NAFLD)

Insulin resistance drives fat accumulation in the liver. NAFLD affects up to 50% of women with PCOS, and the presence of prediabetes increases both the prevalence and severity of liver involvement. NAFLD can progress to non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma if metabolic health is not restored. Liver enzyme screening should be part of routine care for women with PCOS and prediabetes.

Fertility and Pregnancy Complications

Prediabetes compounds the reproductive challenges already present in PCOS. Hyperinsulinemia directly impairs ovarian function, reduces egg quality, and disrupts endometrial receptivity. Women with PCOS and prediabetes have lower success rates with both natural conception and assisted reproductive technologies. Additionally, the risk of early pregnancy loss is elevated, likely due to impaired placentation and hormonal imbalances.

Pregnancies that do occur carry increased risks of gestational diabetes, preeclampsia, preterm birth, and large-for-gestational-age infants. Addressing metabolic health before conception is one of the most important steps women with PCOS can take to improve pregnancy outcomes.

Obstructive Sleep Apnea

Insulin resistance and central obesity predispose women with PCOS to obstructive sleep apnea (OSA), a condition characterized by repeated episodes of airway collapse during sleep. OSA worsens insulin resistance, increases cardiovascular risk, and contributes to daytime fatigue and cognitive impairment. Screening for sleep-disordered breathing should be considered in women with PCOS who have obesity, snoring, or excessive daytime sleepiness.

Lifestyle Strategies for Prevention and Management

Lifestyle modification is the foundation of managing both PCOS and prediabetes. Even modest changes can produce significant improvements in metabolic and reproductive outcomes.

Nutritional Approaches

No single diet is universally recommended for PCOS and prediabetes, but several evidence-based principles guide effective nutritional therapy.

  • Low glycemic index (GI) carbohydrates: Choosing whole grains, legumes, non-starchy vegetables, and whole fruits over refined alternatives reduces post-meal glucose spikes and insulin surges. Examples include steel-cut oats, quinoa, lentils, sweet potatoes, and berries.
  • Adequate protein intake: Including lean protein sources such as poultry, fish, eggs, tofu, and legumes at each meal improves satiety, stabilizes blood sugar, and supports muscle maintenance during weight loss.
  • Healthy fats: Unsaturated fats from olive oil, avocados, nuts, seeds, and fatty fish reduce inflammation and improve lipid profiles. Omega-3 fatty acids, in particular, show benefits for insulin sensitivity and ovarian function.
  • Fiber-rich foods: Vegetables, fruits, legumes, and whole grains provide soluble and insoluble fiber that slows glucose absorption, feeds beneficial gut bacteria, and promotes fullness. Aim for at least 25–30 grams of fiber daily.
  • Limiting added sugars and refined grains: Sugary beverages, candy, pastries, white bread, and white rice should be minimized or eliminated. These foods rapidly elevate blood glucose and insulin, directly worsening both PCOS and prediabetes.
  • Meal timing and frequency: Some research supports early time-restricted feeding, where eating is limited to an 8–10 hour window during the day, as a strategy to improve insulin sensitivity. Regular meal spacing, avoiding large late-night meals, and reducing snacking can also help.

A registered dietitian specializing in PCOS and metabolic health can help women develop individualized meal plans that are sustainable and culturally appropriate.

Physical Activity

Exercise directly enhances insulin sensitivity by increasing glucose uptake into muscle cells independent of insulin. The benefits are immediate and accumulate over time.

  • Aerobic exercise: Brisk walking, jogging, cycling, swimming, or dancing for at least 150 minutes per week at moderate intensity improves cardiovascular fitness and glucose disposal. Breaking this into 30-minute sessions five days per week is practical for most women.
  • Resistance training: Two to three sessions per week of weight lifting, bodyweight exercises, or resistance bands build muscle mass, which is a major site of glucose uptake. More muscle means better metabolic health.
  • High-intensity interval training (HIIT): Short bursts of intense effort followed by recovery periods have been shown to improve insulin sensitivity and reduce androgen levels in women with PCOS. HIIT can be time-efficient and effective but should be introduced gradually.
  • Non-exercise activity thermogenesis (NEAT): Daily movement outside of structured exercise—walking during phone calls, taking stairs, gardening, housework—contributes significantly to total energy expenditure and metabolic health.

Consistency matters more than intensity, especially in the beginning. Women with PCOS often struggle with fatigue and joint discomfort; starting with low-impact activities and progressing gradually helps build sustainable habits.

Weight Management

A 5–10% reduction in body weight can produce clinically meaningful improvements in insulin sensitivity, androgen levels, ovulation, and cardiovascular risk markers. For a woman weighing 200 pounds (91 kg), this means losing 10–20 pounds (4.5–9 kg). Weight loss is more challenging in the presence of insulin resistance, but a combination of dietary changes, physical activity, behavioral strategies, and medical support when needed can succeed.

Focusing on health behaviors rather than the number on the scale reduces the psychological burden of weight management and supports long-term adherence. Non-scale victories such as improved energy, regular periods, clearer skin, and better mood are equally important markers of progress.

Medical and Pharmacological Interventions

When lifestyle changes alone are insufficient to reverse prediabetes or adequately manage PCOS symptoms, medical treatments can help.

Metformin

Metformin is the most extensively studied and widely prescribed medication for metabolic dysfunction in PCOS. It works primarily by reducing glucose production in the liver and improving peripheral insulin sensitivity. In women with PCOS, metformin has been shown to lower fasting insulin and glucose, reduce androgen levels, restore ovulatory cycles, and slow or prevent progression from prediabetes to type 2 diabetes.

Typical dosing starts at 500 mg once or twice daily with meals, titrating up to 1500–2000 mg daily as tolerated. An extended-release formulation is available and often causes fewer gastrointestinal side effects such as nausea, diarrhea, and abdominal discomfort. Side effects are most common in the first few weeks and usually improve with gradual dose escalation and consistent food intake.

Metformin is not a substitute for lifestyle modification, but it is a valuable adjunct. It is considered safe for long-term use and may also offer cardiovascular benefits independent of glucose lowering.

Inositol Supplementation

Myo-inositol and D-chiro-inositol are naturally occurring compounds that act as insulin sensitizers. They function as second messengers in the insulin signaling pathway, improving glucose uptake and reducing circulating insulin levels. Clinical trials have demonstrated that inositol supplementation can improve insulin sensitivity, lower triglycerides, reduce testosterone, and restore ovulation in women with PCOS.

The optimal ratio appears to be 40:1 myo-inositol to D-chiro-inositol, typically provided as 2 grams of myo-inositol and 50 mg of D-chiro-inositol twice daily. Quality and purity vary among brands, so choosing products from reputable manufacturers is important. Inositol is generally well tolerated with minimal side effects, making it an attractive option for women seeking natural approaches.

GLP-1 Receptor Agonists

Glucagon-like peptide-1 (GLP-1) receptor agonists such as liraglutide, semaglutide, and tirzepatide have emerged as powerful tools for managing obesity and type 2 diabetes. These medications enhance insulin secretion, slow gastric emptying, promote satiety, and induce significant weight loss. Emerging evidence supports their use in women with PCOS who have obesity and prediabetes, particularly when other interventions have not achieved adequate results.

These drugs are administered by injection, typically once weekly, and require careful medical supervision due to potential side effects including nausea, vomiting, diarrhea, and, rarely, pancreatitis or gallbladder disease. They are generally reserved for women with a body mass index (BMI) above 30 or above 27 with at least one weight-related complication, in conjunction with comprehensive lifestyle support.

Anti-Androgen Medications

Medications that block androgen production or action, such as spironolactone, finasteride, or oral contraceptives containing anti-androgenic progestins, can improve PCOS symptoms like hirsutism, acne, and hair thinning. These medications do not directly treat insulin resistance or prediabetes, but they can improve quality of life and complement metabolic interventions. Spironolactone is the most commonly used anti-androgen in PCOS; it is typically taken at doses of 50–200 mg daily and requires monitoring of potassium levels and kidney function.

The Critical Importance of Early Detection and Regular Screening

Given the high prevalence and silent progression of prediabetes in women with PCOS, routine screening is essential. The American Diabetes Association recommends that all women with PCOS be screened for type 2 diabetes starting at age 25 or at the time of PCOS diagnosis if younger. Screening should be repeated every one to three years, or more frequently if additional risk factors are present.

The optimal screening test remains a topic of debate. HbA1c is convenient and does not require fasting, but it can miss some cases of prediabetes, particularly in women with anemia or certain hemoglobin variants. The oral glucose tolerance test (OGTT) is more sensitive and captures postprandial glucose abnormalities that may occur despite normal fasting glucose. Many experts recommend OGTT for women with PCOS given the high metabolic risk.

Screening should go beyond glucose testing. Annual assessment of blood pressure, fasting lipid panel, liver enzymes, and thyroid function provides a comprehensive picture of metabolic health. Vitamin D deficiency is also common in PCOS and linked to insulin resistance, so checking 25-hydroxyvitamin D levels is reasonable.

Integrating Care: A Whole-Person Approach

The link between PCOS and prediabetes demands an integrated approach to care that addresses both conditions simultaneously rather than treating them in isolation. No single specialist can address all aspects of PCOS-related metabolic health; collaboration among healthcare providers is essential.

An ideal care team includes an endocrinologist or internist with expertise in metabolic disorders, a gynecologist or reproductive endocrinologist, a registered dietitian, a mental health professional, and, when needed, a sleep medicine specialist or cardiologist. Care coordination ensures that interventions are aligned, medications are not duplicated, and lifestyle recommendations are consistent.

Patient education and empowerment are equally important. Women with PCOS who understand the bidirectional relationship between their condition and prediabetes are more likely to engage in preventive behaviors, adhere to treatment plans, and advocate for appropriate screening. Support groups, online communities, and credible educational resources can provide ongoing motivation and validation.

Moving Forward: Taking Action Today

The connection between prediabetes and PCOS is not a matter of chance; it is woven into the fabric of these intertwined conditions through insulin resistance, inflammation, and hormonal dysregulation. Prediabetes represents a critical window for intervention, a period when progression to type 2 diabetes is still reversible and when improvements in metabolic health directly translate into better PCOS outcomes.

For women living with PCOS, the most important steps are to know their metabolic status through regular screening, adopt dietary and physical activity patterns that support insulin sensitivity, achieve and maintain a healthy weight, and work with a healthcare team that understands the full scope of the condition. Medications such as metformin, inositol, and GLP-1 receptor agonists can provide additional support when needed.

The science is clear: PCOS is not just a reproductive disorder. It is a lifelong metabolic condition that requires ongoing attention to prevent the development of diabetes, cardiovascular disease, and other complications. By embracing this broader perspective, women with PCOS can take control of their health, reduce their risk, and live fuller, healthier lives.

Early intervention changes everything. The time to act is now.

Additional Resources and References